{"id":828479,"date":"2025-03-21T08:34:51","date_gmt":"2025-03-21T12:34:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/"},"modified":"2025-03-21T08:34:51","modified_gmt":"2025-03-21T12:34:51","slug":"fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/","title":{"rendered":"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">HOUSTON, March  21, 2025  (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Hamid Khoja, Ph.D., Chief Scientific Officer of FibroBiologics, will present on FibroBiologics\u2019 unique fibroblast cell-based approach for the potential treatment of chronic diseases at The German-Nordic Joint Extracellular Matrix Meeting in Freiburg, Germany, from March 26-28, 2025. The joint meeting is an annual opportunity to showcase advances in extracellular matrix biology.<\/p>\n<p align=\"justify\">Dr. Khoja commented, \u201cFibroblasts are a critical component of the extracellular matrix with regenerative and immunomodulatory properties. Our presentation will detail the progress we\u2019ve made in expanding our portfolio and targeting additional indications by leveraging the unique potential of fibroblasts.\u201d<\/p>\n<p align=\"justify\">Details of the conference and presentations are as follows:<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>The German-Nordic Joint Extracellular Matrix Meeting<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Presentation Title: <\/strong>Potential Treatment of Chronic Diseases With the Aim of Immune System Homeostasis Rather Than Depletion or Over-activation.<\/p>\n<p align=\"justify\">\n        <strong>Presenter: <\/strong>Hamid Khoja, Ph.D., Chief Scientific Officer, FibroBiologics<\/p>\n<p align=\"justify\">\n        <strong>Location: <\/strong>Otto-Krayer Haus, Albertstrasse 25, Freiburg, Germany<\/p>\n<p align=\"justify\">\n        <strong>Date and Time:<\/strong> Thursday, March 27, at 10:25 a.m. to 12:00 p.m. Central European Time<\/p>\n<p align=\"justify\">For more information, please visit FibroBiologics&#8217; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qVhqt1R5GviVbG4tWs6zg5Sv2DCKoRmwcGSEl7wIMMKnfeeLLI1werwK4a6WP155MwvqvrdGkuNcrAhBjaWjEQ==\" rel=\"nofollow\" target=\"_blank\">website<\/a> or email FibroBiologics at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=16unLDP1FwwIMrIsm8zxbT1sJtvfb0AxLybxSYi-l9EjU1-G6i7G3kmwCFmlfM1PgVPAV1mYPAWk7x16LmEId_MrusZsWT38wsIOiQFeDuE=\" rel=\"nofollow\" target=\"_blank\">info@fibrobiologics.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>About FibroBiologics<\/u><br \/>\n        <\/strong>\u00a0<\/p>\n<p align=\"justify\">Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 160+ US and internationally issued patents\/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy. For more information, visit\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1baNgf-gf7MQ-xClDoJdAR-r2HuARBO2hQEiMSI-GWCp4tPau-WCmFdIfZaHDMb1_LuFYsVTz3RKqC3x739qAaZA-9um8ZBG-UlcsUDd5c6fWA9nAVJnVqSBRDFfat5bmMwj2JCMYvJNsdLEIzmFe5RzkUHEaXKv2tbwpE_Kla1RCj0IzWaG0raTCwwJDHQwNMU2jbCVIIT6mM3XGDfAMDusuryTcV0OstSGQh_GRyy6kaTgHhB0UYiKh7YidEuIF2WhYk7phrSf2Fi0BaKLwgvXDnbfFjJsjLioeBqnDQL9-AGDkogBrsrJlqtV2lmv0RDCpXlWT0YUglYVd3FJENrxUCxXfGExdqHTXQPlqyoZZM9lVkK5iaDMlE7xLQO1HffFcWELv7f5hk4l_cNpsDktcl2bOvNGdjCl4w9dIuGAuHw7M5SNtLVJ5JIKLRhaQYRteZYSZC_BKD2tDKdF_LshI1E06TQUuQlaLS67LXEiGa9CThUsGKYGUGr0Xv4x\" rel=\"nofollow\" target=\"_blank\">www.FibroBiologics.com<\/a>.\u00a0<\/p>\n<p align=\"justify\">\n        <strong>General Inquiries:<\/strong>\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=16unLDP1FwwIMrIsm8zxbT1sJtvfb0AxLybxSYi-l9EGGApBfI0lBlhz3em7d4loYwOWxOQtcaHH9LKzyBRlMNz7kBnm7i7CWLCqxvcpg8ZUjVBpMEtTrTzteW0Pl0PcR3IfcDS23-SmvVAe6DqeOujRs_OIDPAtk6w3kpc5WK5RiuXGe1rsIZKtoEvDVG0T6ylgmivNy6DkeayVyJdfkhMbSOVGdLlHjULBHpmW9X-2kLt7QJ9XbUdxUbC6SM_GgbdtU7QOi5_G2Ov_A6Kmug==\" rel=\"nofollow\" target=\"_blank\">info@fibrobiologics.com<\/a>\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations:<\/strong>\u00a0<br \/>Nic Johnson\u00a0<br \/>Russo Partners\u00a0<br \/>(212) 845-4242\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TAD2kc2qiWzvYT8OadTTfnMWZboP7T5hNo_vjVDm4oXg6xVOXPzdQ0aorV5LTDwVcui949uN5E5Ui_4-eaU2VltfH-4fyYLEeCi86uGEvE20Fn-g127T3g8UDydIqnQniP8vhtd8nvbg5ACFd0VrrwgJ8uwqlmDlfqXzIqtvpDTrynOVR5MDFyQN5NitNfZDcPZooOnTkLzRdhYSVygwI7__i424lewCNm3X_ZIGllpQ2zTrf6wHRBcJjtyfcEepUsQaPOhoIzN81x72FyQThOTs2I6KY_ZWrv1ImexmqD3atPJtAUUMQ4o50CLjQFVH\" rel=\"nofollow\" target=\"_blank\">fibrobiologicsIR@russopr.com<\/a>\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Media Contact:<\/strong>\u00a0<br \/>Liz Phillips\u00a0<br \/>Russo Partners\u00a0<br \/>(347) 956-7697\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YktU60rGAsDrN0KZkNiqTOvrkAiMrlTJYnZD2upkm9Ryp9IWXEWba0unXZyqXJRDSJCk_Vou13cWxcACt3j9os42l7rxssuxw7fo-K6X_XtX92T1oAWh_qDM4wZjIkgIEkmp96ICNVjApLV_ip1iF9gwd4LO-dADQpJjCwFOHmsHbf4NNVexkh57eskxtGgWX-8v3Mqsm5NQkaeBnyMt-W4smbYrcbOE9KPm1w261fd_DMl1lmnqmyOSCyI84jdlMrwgH-qgHC98-3MY4WPydjFf1qFVoFmoWasFWER2n-8bRR5AU79DpfWlfO5t_qUqEN0exNL1BwCDRG_1eNxTbD1gwBU6c2DzyMgeDZkSSCw=\" rel=\"nofollow\" target=\"_blank\">Elizabeth.phillips@russopartnersllc.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Njk2YjE4MWEtNjA0Zi00YzFlLThmMGQtMzU2NzRhMmVjYTRmLTEyNzUwODEtMjAyNS0wMy0yMS1lbg==\/tiny\/Fibrobiologics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Hamid Khoja, Ph.D., Chief Scientific Officer of FibroBiologics, will present on FibroBiologics\u2019 unique fibroblast cell-based approach for the potential treatment of chronic diseases at The German-Nordic Joint Extracellular Matrix Meeting in Freiburg, Germany, from March 26-28, 2025. The joint meeting is an annual opportunity to showcase advances in extracellular matrix biology. Dr. Khoja commented, \u201cFibroblasts are a critical component of the extracellular matrix with regenerative and immunomodulatory properties. Our presentation will detail the progress we\u2019ve made &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-828479","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Hamid Khoja, Ph.D., Chief Scientific Officer of FibroBiologics, will present on FibroBiologics\u2019 unique fibroblast cell-based approach for the potential treatment of chronic diseases at The German-Nordic Joint Extracellular Matrix Meeting in Freiburg, Germany, from March 26-28, 2025. The joint meeting is an annual opportunity to showcase advances in extracellular matrix biology. Dr. Khoja commented, \u201cFibroblasts are a critical component of the extracellular matrix with regenerative and immunomodulatory properties. Our presentation will detail the progress we\u2019ve made &hellip; Continue reading &quot;FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-21T12:34:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting\",\"datePublished\":\"2025-03-21T12:34:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/\",\"name\":\"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=\",\"datePublished\":\"2025-03-21T12:34:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/","og_locale":"en_US","og_type":"article","og_title":"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - Market Newsdesk","og_description":"HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Hamid Khoja, Ph.D., Chief Scientific Officer of FibroBiologics, will present on FibroBiologics\u2019 unique fibroblast cell-based approach for the potential treatment of chronic diseases at The German-Nordic Joint Extracellular Matrix Meeting in Freiburg, Germany, from March 26-28, 2025. The joint meeting is an annual opportunity to showcase advances in extracellular matrix biology. Dr. Khoja commented, \u201cFibroblasts are a critical component of the extracellular matrix with regenerative and immunomodulatory properties. Our presentation will detail the progress we\u2019ve made &hellip; Continue reading \"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-21T12:34:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting","datePublished":"2025-03-21T12:34:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/"},"wordCount":319,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/","name":"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=","datePublished":"2025-03-21T12:34:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODM5MiM2ODE3Mjg3IzIyNjM1MzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-the-german-nordic-joint-extracellular-matrix-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=828479"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828479\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=828479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=828479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=828479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}